Article

Nidek launches two new laser systems

Fremont, CA—Nidek Inc. has launched two new lasers to the U.S. market: its fifth-generation Nd:YAG laser solution—the YC-1800 ophthalmic YAG laser system—and the MC-300 multicolor laser photocoagulator system.

Fremont, CA-Nidek Inc. has launched two new lasers to the U.S. market: its fifth-generation Nd:YAG laser solution-the YC-1800 ophthalmic YAG laser system-and the MC-300 multicolor laser photocoagulator system.

The company said the Nd:YAG system boasts innovative laser delivery and output technologies, improved operability, fast operation, adjustable Nd:YAG offset, and a compact design.

Meanwhile, Nidek launched its MC-300 after receiving FDA marketing clearance April 15. The photocoagulator delivers three laser wavelengths-659, 561, and 532 nm-for retinal applications and disease treatments and management, and offers digitally controlled instant duty cycles that allow the laser to be used at rapid speeds and high powers for extended periods.

Related Videos
Arun Gulani, MD: How the Gni instrument enhances precision and control in cataract surgery
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.